Yan Jiang

Title: Yan Jiang: Innovator in Biopharmaceuticals

Introduction

Yan Jiang is a prominent inventor based in Hangzhou, China, known for his significant contributions to the field of biopharmaceuticals. With a total of four patents to his name, he has made remarkable strides in developing innovative treatments for various medical conditions.

Latest Patents

One of Yan Jiang's latest patents is titled "Human endothelin receptor antibody and use thereof." This invention discloses an antibody that specifically binds to a human endothelin receptor, inhibiting its functions. The antibody has potential applications in effectively treating pulmonary arterial hypertension and reproductive organ cancers in humans. Another notable patent is "GCGR antibody and GLP-1 fusion protein thereof, pharmaceutical composition thereof and application thereof." This patent provides a glucagon receptor (GCGR) antibody and its fusion protein with glucagon-like peptide-1 (GLP-1). It also outlines a method for using this combination to treat or improve symptoms of hyperglycemia, type 2 diabetes, metabolic syndrome, or dyslipidemia.

Career Highlights

Yan Jiang is currently associated with Gmax Biopharm LLC, where he continues to push the boundaries of medical research and innovation. His work focuses on developing novel therapeutic solutions that address critical health issues.

Collaborations

Yan collaborates with talented individuals in his field, including Cheng Zhang and Hua Zhang, who contribute to his research endeavors.

Conclusion

Yan Jiang's innovative work in biopharmaceuticals showcases his commitment to advancing medical science and improving patient outcomes. His patents reflect a deep understanding of complex biological systems and a dedication to finding effective treatments for serious health conditions.